Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (91-100 of 183) with videos related to

Pageof 19
Sort By:
Leukemia|October 3, 2002
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cellsB K Arendt, A Velazquez-Dones, R C Tschumper, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Mayo Clinic Proceedings|November 1, 1987
Immunofluorescence labeling indices in myeloma and related monoclonal gammopathiesP R Greipp, T E Witzig, N J Gonchoroff, et al.
Cytometry|January 1, 1990
Effect of sonication on paraffin-embedded tissue preparation for DNA flow cytometryN J Gonchoroff, J J Ryan, T K Kimlinger, et al.
Clinical and Experimental Immunology|August 27, 2015
Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophagesA K Church, K R VanDerMeid, N A Baig, et al.
American Journal of Clinical Oncology|October 16, 1999
Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemiaA Tefferi, R Levitt, C Y Li, et al.
Blood|January 28, 1999
Long-term survival (10 years or more) in 30 patients with primary amyloidosisR A Kyle, M A Gertz, P R Greipp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trialT E Witzig, L Letendre, J Gerstner, et al.
Archives of Pathology & Laboratory Medicine|August 1, 1994
Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disordersD M Menke, P R Greipp, G Colon-Otero, et al.
Blood|August 1, 1995
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 casesJ D Hoyer, C W Ross, C Y Li, et al.
Pageof 19

Showing results (91-100 of 183) with videos related to

Sort By:
Pageof 19
Leukemia|October 3, 2002
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cellsB K Arendt, A Velazquez-Dones, R C Tschumper, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Mayo Clinic Proceedings|November 1, 1987
Immunofluorescence labeling indices in myeloma and related monoclonal gammopathiesP R Greipp, T E Witzig, N J Gonchoroff, et al.
Cytometry|January 1, 1990
Effect of sonication on paraffin-embedded tissue preparation for DNA flow cytometryN J Gonchoroff, J J Ryan, T K Kimlinger, et al.
Clinical and Experimental Immunology|August 27, 2015
Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophagesA K Church, K R VanDerMeid, N A Baig, et al.
American Journal of Clinical Oncology|October 16, 1999
Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemiaA Tefferi, R Levitt, C Y Li, et al.
Blood|January 28, 1999
Long-term survival (10 years or more) in 30 patients with primary amyloidosisR A Kyle, M A Gertz, P R Greipp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trialT E Witzig, L Letendre, J Gerstner, et al.
Archives of Pathology & Laboratory Medicine|August 1, 1994
Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disordersD M Menke, P R Greipp, G Colon-Otero, et al.
Blood|August 1, 1995
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 casesJ D Hoyer, C W Ross, C Y Li, et al.
Pageof 19